As shown in Table 3, no significant differences were observed between the two groups regarding age, sex, time from admission to discharge, diabetes, hypertension, viral encephalitis, epilepsy, sleep disorders, memory impairment, movement dysfunction, speech disorders, red blood well as red blood cells (RBC), platelet count (PLT), monocytes, lymphocytes, basophils, activated partial thromboplastin time (APTT), thrombin time (TT), Alb, MRI, EEG, first- and second-line treatment, long-term immunotherapy, relapse, and other indicators (P > 0.05). This evidence concerns the gene ALB and speech disorder.